Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| GS Griffin Special Opportunities FundCompany profile Griffin Gaming Partners fund providing project financing to independent game developers through revenue-sharing agreements. Griffin Gaming Partners fund providing project financing to independent game developers through revenue-sharing agreements. | $100M | Special Opportunities Fund launchUndisclosed | Media & gaming | United States | Investors Undisclosed | |
| MP Modicus PrimeCompany profile Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries | $4.5M | Undisclosed | Healthtech | United States | Investors | |
| N NanochapCompany profile Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception. Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception. | CN¥300M | Strategic financingUndisclosed | Healthtech | China | Investors | |
| O Provides stablecoin yield infrastructure for fintechs and exchanges | $17M | StrategicUndisclosed | Fintech | United Kingdom | Investors | |
Boost SecurityCompany profile Boost Security develops security software for AI-assisted software development. Boost Security develops security software for AI-assisted software development. | $4M | Undisclosed | Cybersecurity | Canada | Investors | |
4D PathCompany profile Digital biomarkers designed to predict cancer treatment response from routine biopsy images. Digital biomarkers designed to predict cancer treatment response from routine biopsy images. | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors Undisclosed | |
| E ElevenLabsCompany profile Develops voice AI models and audio synthesis tools for enterprise and consumer applications Develops voice AI models and audio synthesis tools for enterprise and consumer applications | Undisclosed | Undisclosed | AI | United States | Investors | |
| N NavidenceCompany profile Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| R ReducinerCompany profile Converts captured CO₂ into carbon monoxide using renewable electricity for use in industrial systems Converts captured CO₂ into carbon monoxide using renewable electricity for use in industrial systems | €3.6M | Undisclosed | Climate tech | Finland | Investors | |
A-CubeCompany profile APIs connecting business software with electronic invoicing, tax reporting and digital document workflows. APIs connecting business software with electronic invoicing, tax reporting and digital document workflows. | €4M | Undisclosed | Fintech | Italy | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.